The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of tenofovir disoproxil fumarate
(tenofovir DF) in combination with other anti-HIV drugs in patients who have participated in
other tenofovir DF studies (GS-98-902 or GS-99-907), are able to tolerate the drug at
different doses, and may benefit from having tenofovir DF treatment.